Optimising HFO&VTV in Newborn Infants

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

27 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-02-26

Study Completion Date

2026-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Mechanical ventilation (MV) is life saving for infants requiring respiratory support in the newborn period but its use has been associated with complications. High frequency oscillation (HFO) is a type of MV that delivers small volumes of gas across the lungs at fast frequencies. HFO is a lung protective strategy but it has also been linked to brain injury due to low carbon dioxide tensions. High-frequency oscillation with volume-targeted ventilation (HFO\&VTV) is a new mode of HFO in which the clinician sets a target volume of gas to be delivered to the lungs at fast rates to decrease the lung injury related to the ventilator. Further, HFO\&VTV achieves better control of carbon dioxide levels and may therefore protect against brain injury. Currently, there are no written guidelines about the use of HFO\&VTV. This study aim to determine the safety profile of HFO\&VTV compared to HFO by comparing the velocity of blood flow to the brain in term born infants and the cardiac output in term and preterm infants during the two modes. The investigators will also determine the optimum starting value of the target tidal volume during HFOV\&VTV. Infants will be studied at three different target tidal volumes for a period of 10-20 minutes each. A cranial ultrasound (for term infants only) and bedside echocardiogram will be performed at the end of each period.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

High Frequency Oscillatory Ventilation Combined With Intermittent Sigh Breaths: Effects on Lung Volume Monitored by Electric Tomography Impedance.

NCT01962818

Respiratory Distress Syndrome In Premature Infants Bronchopulmonary Dysplasia Ventilator-Induced Lung Injury +1 more

COMPLETED NA

Nasal High Frequency Oscillation Ventilation(NHFOV) for Respiratory Distress Syndrome

NCT03140891

Respiratory Distress Syndrome Preterm Infant

COMPLETED NA

Nasal High Frequency Oscillatory Versus Nasal Intermittent Positive Pressure Ventilation in Neonate After Extubation

NCT02543125

Respiratory Insufficiency

UNKNOWN NA

Nasal HFOV Versus Nasal SIPPV in Neonate Following Extubation: RCT Crossover Study

NCT04323397

High-Frequency Ventilation Intermittent Positive-Pressure Ventilation Newborn Morbidity +1 more

COMPLETED NA

NHFOV Vs NIPPV Post-extubation in Preterm Neonates

NCT06620107

Noninvasive Ventilation

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a single centre, randomised cross-over trial in newborn infants requiring high-frequency oscillatory ventilation (HFOV) at any postnatal age. Infants with known intracerebral pathology (stroke, hydrocephalus, intracerebral haemorrhage, severe HIE) and congenital cardiac abnormalities will be excluded from the study. In preterm infants cerebral blood flow will not be studied as there is no clear evidence for the significance of the resistive index (RI) in the cerebral arteries to predict brain injury and neurodevelopmental outcomes.

The research team will identify infants based on the inclusion criteria and approach parents to discuss the study and provide information leaflets.

The investigators aim to recruit a minimum of 25 infants (13 preterm and 12 term infants) over 18 months.

Informed written consent will be requested from the parents or legal guardians of the infants and the attending Neonatal Consultant will be requested to verbally assent to the study.

All infants will be oscillated using SLE6000 ventilators. Ventilation settings will be adjusted by the clinical team as per unit's protocol.

Infants will be studied when clinically stable and a blood gas confirms that the carbon dioxide (CO2) levels are in the target range (4.5 to 6.5 kPa). Participants will receive HFO\&VTV at targeted tidal volumes of 1.5, 2.0 and 2.5 ml/kg in random order for a period of 10-20 minutes each. Additionally, there will be a control period of 20 minutes between each tidal volume when infants will be switched to HFOV without volume-guarantee at the settings applied prior to the study. The order in which they receive the different levels of tidal volumes will be randomised using an excel random number generator.

Transcutaneous CO2 monitoring will be applied to the infants during the study. The resistive index (RI) as an indicator of cerebral blood flow in term infants and the cardiac output of all paticipants will be assessed at the last five minutes of each twenty-minute period. Measurements of the RI and the cardiac output will also be made during the last five minutes of the control periods and the results will be averaged.

The nurse to patient ration will be according to the unit's protocol that is determined on the patient's acuity.

The investigators will also record basic epidemiologic parameters such as sex, gestational age, birth weight, mode of delivery, Apgar scores, administration of surfactant, day of life at study, mechanical ventilation starting time and HFO starting time, and initial diagnosis.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

High Frequency Oscillation Volume Targeted Ventilation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

High frequency oscillation at the settings applied prior to the study

Group Type ACTIVE_COMPARATOR

HFOV at the settings applied prior to the study

Intervention Type OTHER

HFOV at the settings applied prior to the study

High frequency oscillation with volume targeted ventilation

Group Type ACTIVE_COMPARATOR

HFO&VTV at targeted tidal volumes of 1.5, 2.0 and 2.5 ml/kg in random order

Intervention Type OTHER

HFO\&VTV at targeted tidal volumes of 1.5, 2.0 and 2.5 ml/kg in random order

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

HFO&VTV at targeted tidal volumes of 1.5, 2.0 and 2.5 ml/kg in random order

HFO\&VTV at targeted tidal volumes of 1.5, 2.0 and 2.5 ml/kg in random order

Intervention Type OTHER

HFOV at the settings applied prior to the study

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

-Newborn infants of any gestation receiving high frequency oscillatory ventilation

Exclusion Criteria

* Infants with known intracerebral pathology (stroke, hydrocephalus, intracerebral hemorrhage, severe hypoxic ischemic encephalopathy).
* Infants with congenital cardiac abnormalities.

Minimum Eligible Age

22 Weeks

Maximum Eligible Age

1 Year

Eligible Sex

ALL

Accepts Healthy Volunteers

No